Zacks Podcast Highlights: Immunotherapy Stocks 101: What Biotech Investors Need to Know Now – Nasdaq
|
Zacks Podcast Highlights: Immunotherapy Stocks 101: What Biotech Investors Need to Know Now
Nasdaq Chicago, IL – In this edition of the Dutram Report , Eric Dutram talks with Brad Loncar, the CEO of Loncar Investments. Brad specializes in the world of immunotherapy, a technique that is revolutionizing the cancer treatment market by harnessing the … |
